Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nasdaq Biotechnology Ishares ETF (NQ: IBB ) 144.90 +0.66 (+0.46%) Official Closing Price Updated: 4:15 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nasdaq Biotechnology Ishares ETF < Previous 1 2 3 4 5 6 7 8 9 ... 24 25 Next > Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases August 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate August 04, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial August 03, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study August 02, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial August 01, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Biotech Investors: August's Key PDUFA Catalysts You Must Know July 31, 2022 Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to be positive. That said, none of the drugs approved during the... Via Benzinga Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update July 29, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate July 28, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Granny Retail and Granddad Russell Dish Post FOMC July 27, 2022 If the Fed is perceived as not able to do the hard rate raise and control inflation, the consumer will continue to feel the pinch of higher prices on real goods. Via Talk Markets Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy July 27, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate July 26, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Expectations, Implications And Possible Impacts On The Market July 25, 2022 Investors believe that the Fed Funds rate is close to peaking and will begin to decline in 2023 and 2024. Via Talk Markets Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact July 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Market Predictions 2022: When Will Stocks Go Back Up? July 22, 2022 As investors look to jump back in, they’re asking, “when will stocks go back up?” It turns out that the bulls and bears are both right. Via InvestorPlace Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset July 22, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners July 21, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study July 20, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings July 19, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 7 Biotech Stocks to Buy for Q3 July 18, 2022 These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential. Via InvestorPlace The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine July 18, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate July 15, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures July 14, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga USD & EUR: Is This the Dollar’s Last Hurrah? July 13, 2022 The euro has been under pressure recently, with investors pulling their money out in favor of the haven currency—the US Dollar. Via Talk Markets The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program July 13, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Strengthen Your Portfolio With Real Assets July 12, 2022 As we head into the second half of the year, it's essential to keep an eye on real assets. Real asset prices provide clues to what's happening in the global economy and can provide valuable insight. Via Talk Markets The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner July 12, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga What Are the Corporate Bond Markets Telling Us? July 11, 2022 Keep an eye on these two corporate bonds ETFs to stay ahead of the curve in the stock market. Via Talk Markets The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death July 11, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Walking The Fine Line - Five Indicators To Tell You When It Is Safe To Invest July 10, 2022 Daily, forecasters claim that we have probably started a recession (NOT) and that Energy prices will continue to climb (while they’ve declined over 10% in the past few weeks). Via Talk Markets 5 Best Stocks to Buy if You Have $100 to Spend July 10, 2022 My son became an investor this year, taking a job that pays more than his single, frugal lifestyle consumes. He asked me what stocks he might buy with Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 ... 24 25 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.